Construction
Compare Stocks
5 / 10Stock Comparison
JCI vs ETN vs HON vs EMR vs GE
Revenue, margins, valuation, and 5-year total return — side by side.
Industrial - Machinery
Conglomerates
Industrial - Machinery
Aerospace & Defense
JCI vs ETN vs HON vs EMR vs GE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Construction | Industrial - Machinery | Conglomerates | Industrial - Machinery | Aerospace & Defense |
| Market Cap | $85.23B | $155.02B | $136.91B | $79.02B | $316.20B |
| Revenue (TTM) | $24.43B | $28.52B | $36.76B | $18.32B | $48.35B |
| Net Income (TTM) | $3.53B | $3.99B | $4.10B | $2.44B | $8.66B |
| Gross Margin | 36.6% | 36.9% | 36.9% | 52.7% | 34.8% |
| Operating Margin | 13.6% | 18.1% | 14.9% | 19.8% | 18.5% |
| Forward P/E | 29.4x | 30.0x | 20.5x | 21.7x | 40.0x |
| Total Debt | $11.19B | $11.17B | $34.58B | $13.76B | $20.49B |
| Cash & Equiv. | $379M | $622M | $12.49B | $1.54B | $12.39B |
JCI vs ETN vs HON vs EMR vs GE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Johnson Controls In… (JCI) | 100 | 443.3 | +343.3% |
| Eaton Corporation p… (ETN) | 100 | 470.2 | +370.2% |
| Honeywell Internati… (HON) | 100 | 148.1 | +48.1% |
| Emerson Electric Co. (EMR) | 100 | 231.2 | +131.2% |
| GE Aerospace (GE) | 100 | 925.2 | +825.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: JCI vs ETN vs HON vs EMR vs GE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
JCI ranks third and is worth considering specifically for valuation efficiency.
- PEG 1.15 vs HON's 11.18
- +56.9% vs HON's +2.8%
ETN is the clearest fit if your priority is long-term compounding.
- 6.1% 10Y total return vs JCI's 343.3%
- 9.0% ROA vs HON's 5.3%, ROIC 13.6% vs 12.6%
HON carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 15 yrs, beta 0.74, yield 2.1%
- Lower volatility, beta 0.74, current ratio 1.32x
- Beta 0.74, yield 2.1%, current ratio 1.32x
- Lower P/E (20.5x vs 40.0x)
Among these 5 stocks, EMR doesn't own a clear edge in any measured category.
GE is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 18.5%, EPS growth 36.2%, 3Y rev CAGR 16.3%
- 18.5% revenue growth vs JCI's 2.8%
- 17.9% margin vs HON's 11.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 18.5% revenue growth vs JCI's 2.8% | |
| Value | Lower P/E (20.5x vs 40.0x) | |
| Quality / Margins | 17.9% margin vs HON's 11.2% | |
| Stability / Safety | Beta 0.74 vs EMR's 1.52 | |
| Dividends | 2.1% yield, 15-year raise streak, vs EMR's 1.5% | |
| Momentum (1Y) | +56.9% vs HON's +2.8% | |
| Efficiency (ROA) | 9.0% ROA vs HON's 5.3%, ROIC 13.6% vs 12.6% |
JCI vs ETN vs HON vs EMR vs GE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
JCI vs ETN vs HON vs EMR vs GE — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
EMR leads in 1 of 6 categories
HON leads 1 • ETN leads 1 • GE leads 1 • JCI leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
EMR leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
GE is the larger business by revenue, generating $48.4B annually — 2.6x EMR's $18.3B. GE is the more profitable business, keeping 17.9% of every revenue dollar as net income compared to HON's 11.2%. On growth, GE holds the edge at +24.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $24.4B | $28.5B | $36.8B | $18.3B | $48.4B |
| EBITDAEarnings before interest/tax | $3.9B | $5.9B | $6.5B | $4.7B | $9.9B |
| Net IncomeAfter-tax profit | $3.5B | $4.0B | $4.1B | $2.4B | $8.7B |
| Free Cash FlowCash after capex | $1.4B | $4.7B | $4.2B | $3.1B | $7.5B |
| Gross MarginGross profit ÷ Revenue | +36.6% | +36.9% | +36.9% | +52.7% | +34.8% |
| Operating MarginEBIT ÷ Revenue | +13.6% | +18.1% | +14.9% | +19.8% | +18.5% |
| Net MarginNet income ÷ Revenue | +14.5% | +14.0% | +11.2% | +13.3% | +17.9% |
| FCF MarginFCF ÷ Revenue | +5.7% | +16.5% | +11.4% | +17.0% | +15.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +8.2% | +16.8% | -6.9% | +2.9% | +24.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +38.9% | -9.4% | -41.9% | +28.2% | -1.1% |
Valuation Metrics
HON leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 29.4x trailing earnings, HON trades at a 45% valuation discount to JCI's 52.9x P/E. Adjusting for growth (PEG ratio), ETN offers better value at 1.55x vs HON's 15.99x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $85.2B | $155.0B | $136.9B | $79.0B | $316.2B |
| Enterprise ValueMkt cap + debt − cash | $96.0B | $165.6B | $159.0B | $91.2B | $324.3B |
| Trailing P/EPrice ÷ TTM EPS | 52.95x | 38.17x | 29.36x | 34.92x | 37.09x |
| Forward P/EPrice ÷ next-FY EPS est. | 29.38x | 30.00x | 20.52x | 21.71x | 40.02x |
| PEG RatioP/E ÷ EPS growth rate | 2.06x | 1.55x | 15.99x | 7.73x | 3.14x |
| EV / EBITDAEnterprise value multiple | 26.01x | 27.69x | 19.99x | 18.07x | 32.46x |
| Price / SalesMarket cap ÷ Revenue | 3.61x | 5.65x | 3.66x | 4.39x | 6.90x |
| Price / BookPrice ÷ Book value/share | 7.03x | 7.99x | 9.00x | 3.94x | 17.09x |
| Price / FCFMarket cap ÷ FCF | 88.32x | 34.67x | 25.39x | 29.63x | 43.53x |
Profitability & Efficiency
ETN leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
GE delivers a 45.8% return on equity — every $100 of shareholder capital generates $46 in annual profit, vs $12 for EMR. ETN carries lower financial leverage with a 0.57x debt-to-equity ratio, signaling a more conservative balance sheet compared to HON's 2.24x. On the Piotroski fundamental quality scale (0–9), EMR scores 7/9 vs GE's 6/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +24.9% | +20.8% | +23.1% | +12.1% | +45.8% |
| ROA (TTM)Return on assets | +9.0% | +9.0% | +5.3% | +5.8% | +6.8% |
| ROICReturn on invested capital | +8.5% | +13.6% | +12.6% | +8.2% | +24.7% |
| ROCEReturn on capital employed | +9.8% | +16.8% | +12.6% | +10.0% | +9.6% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 6 | 6 | 7 | 6 |
| Debt / EquityFinancial leverage | 0.86x | 0.57x | 2.24x | 0.68x | 1.08x |
| Net DebtTotal debt minus cash | $10.8B | $10.5B | $22.1B | $12.2B | $8.1B |
| Cash & Equiv.Liquid assets | $379M | $622M | $12.5B | $1.5B | $12.4B |
| Total DebtShort + long-term debt | $11.2B | $11.2B | $34.6B | $13.8B | $20.5B |
| Interest CoverageEBIT ÷ Interest expense | 18.41x | 16.38x | 3.92x | 6.46x | 11.69x |
Total Returns (Dividends Reinvested)
GE leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GE five years ago would be worth $46,249 today (with dividends reinvested), compared to $10,326 for HON. Over the past 12 months, JCI leads with a +56.9% total return vs HON's +2.8%. The 3-year compound annual growth rate (CAGR) favors GE at 56.0% vs HON's 5.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +14.2% | +22.3% | +10.9% | +4.3% | -5.5% |
| 1-Year ReturnPast 12 months | +56.9% | +33.2% | +2.8% | +30.4% | +44.9% |
| 3-Year ReturnCumulative with dividends | +127.9% | +141.3% | +16.2% | +75.9% | +280.0% |
| 5-Year ReturnCumulative with dividends | +122.9% | +182.8% | +3.3% | +59.5% | +362.5% |
| 10-Year ReturnCumulative with dividends | +343.3% | +608.7% | +135.1% | +206.6% | +121.0% |
| CAGR (3Y)Annualised 3-year return | +31.6% | +34.1% | +5.1% | +20.7% | +56.0% |
Risk & Volatility
Evenly matched — JCI and HON each lead in 1 of 2 comparable metrics.
Risk & Volatility
HON is the less volatile stock with a 0.74 beta — it tends to amplify market swings less than EMR's 1.52 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JCI currently trades 94.5% from its 52-week high vs EMR's 85.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.97x | 1.42x | 0.74x | 1.52x | 1.14x |
| 52-Week HighHighest price in past year | $147.32 | $435.43 | $248.18 | $165.15 | $348.48 |
| 52-Week LowLowest price in past year | $87.77 | $296.93 | $186.76 | $108.37 | $208.22 |
| % of 52W HighCurrent price vs 52-week peak | +94.5% | +91.7% | +87.1% | +85.4% | +86.8% |
| RSI (14)Momentum oscillator 0–100 | 56.2 | 59.8 | 45.1 | 61.3 | 56.4 |
| Avg Volume (50D)Average daily shares traded | 3.3M | 2.5M | 3.7M | 2.8M | 5.7M |
Analyst Outlook
Evenly matched — HON and EMR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: JCI as "Buy", ETN as "Buy", HON as "Buy", EMR as "Buy", GE as "Buy". Consensus price targets imply 27.6% upside for GE (target: $386) vs -4.9% for ETN (target: $380). For income investors, HON offers the higher dividend yield at 2.14% vs GE's 0.45%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $138.00 | $379.78 | $243.83 | $161.92 | $386.20 |
| # AnalystsCovering analysts | 45 | 39 | 28 | 41 | 34 |
| Dividend YieldAnnual dividend ÷ price | +1.1% | +1.0% | +2.1% | +1.5% | +0.4% |
| Dividend StreakConsecutive years of raises | 5 | 24 | 15 | 37 | 2 |
| Dividend / ShareAnnual DPS | $1.49 | $4.17 | $4.63 | $2.10 | $1.36 |
| Buyback YieldShare repurchases ÷ mkt cap | +7.0% | +1.2% | +2.8% | +1.6% | +2.4% |
EMR leads in 1 of 6 categories (Income & Cash Flow). HON leads in 1 (Valuation Metrics). 2 tied.
JCI vs ETN vs HON vs EMR vs GE: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is JCI or ETN or HON or EMR or GE a better buy right now?
For growth investors, GE Aerospace (GE) is the stronger pick with 18.
5% revenue growth year-over-year, versus 2. 8% for Johnson Controls International plc (JCI). Honeywell International Inc. (HON) offers the better valuation at 29. 4x trailing P/E (20. 5x forward), making it the more compelling value choice. Analysts rate Johnson Controls International plc (JCI) a "Buy" — based on 45 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — JCI or ETN or HON or EMR or GE?
On trailing P/E, Honeywell International Inc.
(HON) is the cheapest at 29. 4x versus Johnson Controls International plc at 52. 9x. On forward P/E, Honeywell International Inc. is actually cheaper at 20. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Johnson Controls International plc wins at 1. 15x versus Honeywell International Inc. 's 11. 18x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — JCI or ETN or HON or EMR or GE?
Over the past 5 years, GE Aerospace (GE) delivered a total return of +362.
5%, compared to +3. 3% for Honeywell International Inc. (HON). Over 10 years, the gap is even starker: ETN returned +608. 7% versus GE's +121. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — JCI or ETN or HON or EMR or GE?
By beta (market sensitivity over 5 years), Honeywell International Inc.
(HON) is the lower-risk stock at 0. 74β versus Emerson Electric Co. 's 1. 52β — meaning EMR is approximately 105% more volatile than HON relative to the S&P 500. On balance sheet safety, Eaton Corporation plc (ETN) carries a lower debt/equity ratio of 57% versus 2% for Honeywell International Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — JCI or ETN or HON or EMR or GE?
By revenue growth (latest reported year), GE Aerospace (GE) is pulling ahead at 18.
5% versus 2. 8% for Johnson Controls International plc (JCI). On earnings-per-share growth, the picture is similar: GE Aerospace grew EPS 36. 2% year-over-year, compared to -15. 5% for Honeywell International Inc.. Over a 3-year CAGR, GE leads at 16. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — JCI or ETN or HON or EMR or GE?
GE Aerospace (GE) is the more profitable company, earning 19.
0% net margin versus 12. 6% for Honeywell International Inc. — meaning it keeps 19. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EMR leads at 19. 6% versus 12. 0% for JCI. At the gross margin level — before operating expenses — EMR leads at 52. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is JCI or ETN or HON or EMR or GE more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Johnson Controls International plc (JCI) is the more undervalued stock at a PEG of 1. 15x versus Honeywell International Inc. 's 11. 18x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Honeywell International Inc. (HON) trades at 20. 5x forward P/E versus 40. 0x for GE Aerospace — 19. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GE: 27. 6% to $386. 20.
08Which pays a better dividend — JCI or ETN or HON or EMR or GE?
All stocks in this comparison pay dividends.
Honeywell International Inc. (HON) offers the highest yield at 2. 1%, versus 0. 4% for GE Aerospace (GE).
09Is JCI or ETN or HON or EMR or GE better for a retirement portfolio?
For long-horizon retirement investors, Honeywell International Inc.
(HON) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 74), 2. 1% yield, +135. 1% 10Y return). Both have compounded well over 10 years (HON: +135. 1%, GE: +121. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between JCI and ETN and HON and EMR and GE?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: JCI is a mid-cap quality compounder stock; ETN is a mid-cap quality compounder stock; HON is a mid-cap quality compounder stock; EMR is a mid-cap quality compounder stock; GE is a large-cap high-growth stock. JCI, ETN, HON, EMR pay a dividend while GE does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.